MétaCan
Menu
← Back to cohort
Record W3171754891 · doi:10.3899/jrheum.210366

Is the Gap in Incidence of Cardiovascular Events in Rheumatoid Arthritis Really Closing?

2021· letter· en· W3171754891 on OpenAlexvenueno aff
Joan M. Bathon

Bibliographic record

VenueThe Journal of Rheumatology · 2021
Typeletter
Languageen
FieldMedicine
TopicRheumatoid Arthritis Research and Therapies
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineRheumatoid arthritisPopulationInflammationInternal medicineImmunologyCardiologyPathology

Abstract

fetched live from OpenAlex

It has been recognized for several decades that individuals with rheumatoid arthritis (RA) have shorter life spans than age- and sex-matched individuals without RA, and that the greatest contribution to this increased mortality in RA is cardiovascular (CV) disease, particularly acute myocardial infarctions (AMIs). In metaanalyses of observational studies, the risk of AMI was 68% higher, and the risk of mortality from AMI 59% higher, in patients with RA compared to general population controls.1,2 The causal factor hypothesized to explain these CV risk differences is the exaggerated inflammatory process that is inherent to RA and persists throughout the disease course of RA to varying degrees. Atherosclerosis has been demonstrated histologically to be an inflammatory process with infiltration of monocytes and T cells as an early event in plaque formation.3 This intraplaque inflammatory process can lead directly to erosion and rupture of plaque membrane through cytokine-induced metalloproteinase production, leading to extrusion of thrombogenic material into the vessel lumen and consequent thrombosis and ischemic events.3 Many of the inflammatory cells and molecules in the inflamed and ruptured plaque are represented in the synovia and blood of patients with RA, suggesting that RA further fuels the atherogenic process. A critical question therefore is whether aggressive reduction of inflammation in RA will reduce the enhanced risk of CV disease relative to the general population, or even to levels below the general population. The treatment of RA has changed dramatically in recent decades, beginning with the introduction of methotrexate (MTX) in the late 1980s, anticytokine and other targeted therapies in the late 1990s, and the emphasis on aggressive treat-to-target management of RA in the 2000s. With these advances, there was an expectation that CV morbidity and mortality in RA would decrease accordingly. Specifically, investigators have asked (1) if CV event … Address correspondence to Dr. J.M. Bathon, MD, Professor of Medicine, Division of Rheumatology, Columbia University Irving Medical Center/New York Presbyterian Hospital, New York, NY 10032, USA. Email: jmb2311{at}columbia.edu.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.035
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Commentary · Consensus signal: none
Teacher disagreement score0.014
Threshold uncertainty score0.055

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0100.035
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.001
Bibliometrics0.0020.004
Science and technology studies0.0010.002
Scholarly communication0.0040.008
Open science0.0020.003
Research integrity0.0060.007
Insufficient payload (model declined to judge)0.0140.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.274
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueThe Journal of Rheumatology→Same topicRheumatoid Arthritis Research and Therapies→French-language works237,207→